Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$39.9K
2.94K shares
What this filing means
HO CAROLE plans to sell 2.94K shares of DENALI THERAPEUTICS INC. valued at approximately $39.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2025ACC: 0001714899-25-000172
Officer· Chief Medical Officer
Since Aug 2018
2.94K
Shares to sell
$39.9K
Approx. market value
2.94K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Lapse - See Remarks
Equity Compensation
8/11/2025
2.94KTotal acquired2.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2025 | Restricted Stock Lapse - See Remarks Equity Compensation | 2.94K | — |
| Total | 2.94K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.94K
Market value
$39.9K
8/12/2025
Total
Units
2.94K
Value
$39.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2025 | 2.94K | $39.9K | NASDAQ | Planned |
| Total | 2.94K | $39.9K | ||